Recent News

• 03.05.2026 - BD Advances Iliac Artery Treatment Across the European Union
• 03.05.2026 - BD Advances Iliac Artery Treatment Across the European Union
• 03.02.2026 - BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation
• 03.02.2026 - BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation
• 02.25.2026 - Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase
• 02.25.2026 - Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap
• 02.23.2026 - BD to Present at Barclays 28th Annual Global Healthcare Conference
• 02.23.2026 - BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency
• 02.19.2026 - Lanesha Minnix Named General Counsel for BD

Recent Filings

• 03.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2026 - 144 Report of proposed sale of securities
• 02.25.2026 - 8-K Current report
• 02.25.2026 - EX-99.1 EX-99.1
• 02.20.2026 - 144 Report of proposed sale of securities
• 02.20.2026 - 144 Report of proposed sale of securities
• 02.18.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.18.2026 - 144 Report of proposed sale of securities